Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal

Показать другие версии (1)

As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer of rituximab (Roche Products) to submit evidence of the clinical and cost effectiveness of rituximab in combination with corticosteroids for treatment of an...

Полное описание

Библиографические подробности
Главные авторы:	Latimer, N, Carroll, C, Wong, R, Tappenden, P, Venning, M, Luqmani, R
Формат:	Journal article
Язык:	English
Опубликовано:	Springer International Publishing 2014

Схожие документы

Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.
по: Latimer, N, и др.
Опубликовано: (2014)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
по: Guerry, M, и др.
Опубликовано: (2012)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
по: Flossmann, O, и др.
Опубликовано: (2006)

Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis
по: Michael A Paley, и др.
Опубликовано: (2019-01-01)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
по: Robson, J, и др.
Опубликовано: (2017)

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
по: Basu, N, и др.
Опубликовано: (2014)

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
по: Pearce, F, и др.
Опубликовано: (2017)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
по: Thomas Hellmark, и др.
Опубликовано: (2019-03-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis following rituximab: Outcomes of 50 patients in a tertiary single centre
по: Fahidah Alenzi, и др.
Опубликовано: (2023-09-01)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
по: Valentina Binda, и др.
Опубликовано: (2021-12-01)

Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
по: Alan D. Salama
Опубликовано: (2020-01-01)

Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
по: Cheng-Hua Weng, и др.
Опубликовано: (2019-12-01)

A disease-specific patient-reported outcome for anti-neutrophil cytoplasmic antibody–associated vasculitis: scale structure and measurement properties of the anti-neutrophil cytoplasmic antibody-associated vasculitis patient-reported outcome measure
по: Robson, J, и др.
Опубликовано: (2017)

Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
по: Saket Jha, и др.
Опубликовано: (2019-01-01)

Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report
по: Xinyu Weng, и др.
Опубликовано: (2022-03-01)

Cardiovascular and Cerebrovascular Outcomes in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis
по: Shiyu Xiao, и др.
Опубликовано: (2024-01-01)

Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
по: Christopher Maximilian Arends, и др.
Опубликовано: (2020-06-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
по: Haiting Wu, и др.
Опубликовано: (2022-04-01)

A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
по: Marta Casal Moura, и др.
Опубликовано: (2022-11-01)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
по: Daisuke Tsukui, и др.
Опубликовано: (2021-01-01)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
по: Hellmich, B, и др.
Опубликовано: (2007)

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients
по: Laura S. van Dam, и др.
Опубликовано: (2020-12-01)

Use of a computerised system to facilitate evaluation of anti-neutrophil cytoplasm (ANCA Associated) vasculitis (AAV) and other forms of systemic vasculitis
по: Luqmani, R, и др.
Опубликовано: (2017)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
по: E. N. Vorkel, и др.
Опубликовано: (2024-12-01)

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
по: Weijun Liu, и др.
Опубликовано: (2024-05-01)

Recent advances in the diagnosis and treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
по: Si-wei Tang, и др.
Опубликовано: (2024-03-01)

Oral Microbiota Profile in Patients with Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
по: Anders Esberg, и др.
Опубликовано: (2022-08-01)

Late Onset of Rivaroxaban-Associated Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
по: Muskan Agarwal MD, и др.
Опубликовано: (2023-10-01)

A case of Sjögren syndrome and anti-neutrophil cytoplasmic antibody-associated vasculitis
по: K. Kaynar, и др.
Опубликовано: (2023-07-01)

Testicular granulomatous vasculitis mimicking testicular torsion in an anti-neutrophil cytoplasmic antibody–associated vasculitis patient
по: Liye Suo, и др.
Опубликовано: (2019-01-01)

Clinical significance of HEp-2 cell cytoplasmic patterns in anti-neutrophil cytoplasmic antibody associated vasculitis
по: Naidan Zhang, MS, и др.
Опубликовано: (2022-06-01)

Clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in French children
по: Salomon R, и др.
Опубликовано: (2011-09-01)

Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis
по: CM Wortel, и др.
Опубликовано: (2025-02-01)

Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians
по: David Massicotte-Azarniouch, и др.
Опубликовано: (2024-08-01)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
по: Mukhtyar, C, и др.
Опубликовано: (2006)

Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
по: Zhi-Ying Li, и др.
Опубликовано: (2020-08-01)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
по: Moog P, и др.
Опубликовано: (2015-11-01)

Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
по: Despina Michailidou, и др.
Опубликовано: (2022-06-01)

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
по: McLaren, J, и др.
Опубликовано: (2001)

Anti-neutrophil cytoplasmic antibody–associated vasculitis complicated with diffuse alveolar haemorrhage and central nervous system vasculitis
по: Takashi Nawata, и др.
Опубликовано: (2021-04-01)